HomeNewsTrendsEntertainmentCoronavirus impact | BARC data reveals surge in TV viewership

Coronavirus impact | BARC data reveals surge in TV viewership

TV content has seen significant growth in consumption for two consecutive weeks as people are confined in their homes due to the coronavirus outbreak.

March 28, 2020 / 13:53 IST
Story continues below Advertisement
Representative image
Representative image

TV channels are witnessing a surge in viewership due to the coronavirus outbreak, according to the latest BARC-Nielsen data.

Total TV consumption witnessed an eight percent jump across the country in the week starting March 14 and viewing time for television increased by over 70 billion minutes.

Story continues below Advertisement

During the January 11 to 31 period, the weekly viewing minutes was recorded at 887 billion, which went up to 959 billion during the March 14 to 20 period.

Track this blog for latest updates on coronavirus outbreak

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show